Minerva Neurosciences, Inc. (NERV)


Stock Price Forecast

May 3, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Minerva Neurosciences, Inc. chart...

About the Company

We do not have any company description for Minerva Neurosciences, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

8

Exchange

Nasdaq

$41M

Total Revenue

8

Employees

$17M

Market Capitalization

-0.52

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NERV News

NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024

on MSN ago, source:

NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of ...

Minerva Neurosciences Inc

3mon ago, source: CNN

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous ...

Minerva Neurosciences: Q1 Earnings Snapshot

3d ago, source: Times Union

BURLINGTON, Mass. (AP) — BURLINGTON, Mass. (AP) — Minerva Neurosciences Inc. (NERV) on Wednesday reported a loss of $8.6 million in its first quarter. On a per-share basis, the Burlington, ...

Minerva Neurosciences Inc NERV

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Minerva Neurosciences, Inc. (NERV)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Minerva Neurosciences, Inc Common Stock (NERV)

9y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Minerva Neurosciences Inc NERV

17d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Minerva Neurosciences Inc.

20d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...